Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy.
Kannan S, Irwin ME, Herbrich SM, Cheng T, Patterson LL, Aitken MJL, Bhalla K, You MJ, Konopleva M, Zweidler-McKay PA, Chandra J.
Kannan S, et al. Among authors: irwin me.
Antioxidants (Basel). 2022 Apr 5;11(4):717. doi: 10.3390/antiox11040717.
Antioxidants (Basel). 2022.
PMID: 35453402
Free PMC article.